County of Los Angeles

County of Los Angeles was paid $7.63M by Medicaid between Jan 2018 and Dec 2024, across 524 billing codes. Its largest line is 0450, Emergency room services — 56% of everything it billed.

33Billing provider infoCOUNTY OF LOS ANGELES
TORRANCE, CA 90502

33aNPI1487865184assigned 05/24/2007

33bProvider typeGeneral Acute Care Hospital

28Total paid$7.63M

24GClaims1,982,627

24DCodes billed524

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#202 of 410

Median peer was paid$6.90M

This provider vs. median1.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	129,850	$21.77
2019	194,724	$300K
2020	215,524	$660K
2021	296,047	$1.19M
2022	354,361	$2.15M
2023	368,610	$2.22M
2024incomplete	423,511	$1.11M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	56%	79,448	70,181	$4.23M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.6%	51,581	49,032	$507K
99205	Prolong outpt/office vis	4.1%	4,431	4,236	$316K
99199	Unlisted special service, procedure or report	3.8%	6,934	6,443	$291K
0206		2.7%	1,920	626	$208K
99281	Emergency department visit for the evaluation and management, self-limited or minor	2.4%	25,855	24,060	$185K
0510		2.1%	11,251	10,004	$160K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.8%	4,526	3,784	$134K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	1.7%	24,649	23,547	$132K
0200		1.6%	815	228	$122K
0131	Inj, acetaminophen (hikma)	1.6%	119	112	$122K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	1.2%	12,096	11,694	$95K

512 more codes

G9008	Coordinated care fee, physician coordinated care oversight services	1.2%	7,466	$91K
99215	Doctor's office visit, returning patient (complex)	1.0%	12,201	$79K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	1,679	$71K
0111		<1%	110	$65K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	4,695	$53K
0760		<1%	2,320	$50K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	12,839	$47K
99221		<1%	1,741	$45K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,134	$32K
90715		<1%	4,851	$30K
G0384	Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	78	$25K
74174		<1%	5,329	$21K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,513	$19K
92100		<1%	1,818	$16K
92250		<1%	4,413	$16K
70450	Computed tomography, head or brain; without contrast material	<1%	5,128	$15K
96375	Therapeutic injection; each additional sequential IV push	<1%	1,184	$15K
0100		<1%	10,713	$13K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	2,416	$12K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	4,822	$12K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,126	$11K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,046	$11K
J1815	Injection, insulin, per 5 units	<1%	477	$10K
G9012	Other specified case management service not elsewhere classified	<1%	17	$9K
71045	Radiologic examination, chest; single view	<1%	17,396	$9K
80053	Comprehensive metabolic panel	<1%	23,063	$9K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,426	$8K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	514	$8K
76770		<1%	782	$8K
99213	Doctor's office visit, returning patient (routine)	<1%	76,218	$8K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	50,521	$7K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	20,668	$7K
71046	Radiologic examination, chest; 2 views	<1%	22,600	$7K
87536		<1%	952	$7K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,598	$6K
92082		<1%	1,763	$6K
93971		<1%	3,467	$6K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	26,280	$5K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,705	$5K
83036	Hemoglobin; glycosylated (A1C)	<1%	15,537	$5K
92285		<1%	1,064	$5K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,842	$5K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	337	$5K
72125	Computed tomography, cervical spine; without contrast material	<1%	712	$5K
80061	Lipid panel	<1%	10,138	$5K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	4,543	$5K
78816		<1%	12	$5K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	5,644	$4K
87522	Neg quan hep c or qual rna	<1%	3,184	$4K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	5,740	$4K
90670		<1%	610	$4K
80048	Basic metabolic panel (calcium, ionized)	<1%	18,960	$4K
84443	Thyroid stimulating hormone (TSH)	<1%	5,639	$4K
71275	Computed tomographic angiography, chest, with contrast material	<1%	612	$4K
96361	Intravenous infusion, hydration; each additional hour	<1%	341	$4K
0516		<1%	176	$4K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	18,723	$4K
73564		<1%	3,628	$4K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	843	$3K
90698		<1%	1,158	$3K
86480		<1%	1,898	$3K
92134		<1%	5,456	$3K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,995	$3K
99203	Doctor's office visit, new patient (routine)	<1%	7,501	$3K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	50,473	$3K
71250		<1%	205	$3K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,080	$3K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	11,770	$3K
76827		<1%	527	$3K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	54	$3K
92132		<1%	353	$3K
86359		<1%	653	$2K
99381		<1%	496	$2K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	570	$2K
92557		<1%	1,897	$2K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,530	$2K
73630		<1%	4,106	$2K
99214	Doctor's office visit, returning patient (more involved)	<1%	61,777	$2K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	575	$2K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	5,784	$2K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	688	$2K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	1,546	$2K
73130		<1%	2,702	$2K
76642		<1%	260	$2K
88342		<1%	2,655	$2K
73610		<1%	3,140	$2K
93247		<1%	965	$2K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	403	$2K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	537	$2K
73110		<1%	2,446	$2K
92133		<1%	1,459	$2K
73200		<1%	414	$2K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	11,093	$2K
73590		<1%	2,042	$2K
86703		<1%	3,457	$2K
74183		<1%	40	$1K
93926		<1%	480	$1K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,320	$1K
73030		<1%	2,074	$1K
83970		<1%	371	$1K
82043		<1%	5,334	$1K
80076		<1%	2,437	$1K
83735		<1%	6,547	$1K
85027		<1%	6,432	$1K
86780		<1%	2,336	$1K
20610		<1%	997	$1K
73700		<1%	322	$1K
90710		<1%	1,235	$1K
Q3014	Telehealth originating site facility fee	<1%	487	$1K
88341		<1%	258	$1K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	603	$1K
84439		<1%	2,091	$996.08
74170		<1%	25	$972.13
90744		<1%	812	$963.27
85610		<1%	6,223	$961.34
99204	Doctor's office visit, new patient (more involved)	<1%	10,908	$948.16
84702		<1%	1,117	$940.51
77065	Tomosynthesis, mammo	<1%	29	$927.59
82540		<1%	4,900	$920.01
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	15	$918.02
84153		<1%	1,430	$908.22
81001		<1%	10,967	$904.60
73080		<1%	979	$900.31
86850		<1%	1,967	$888.62
36415	Collection of venous blood by venipuncture	<1%	278,300	$866.48
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	4,124	$857.32
85730		<1%	2,797	$844.00
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,831	$823.35
82728		<1%	1,663	$819.86
87086	Culture, bacterial; quantitative colony count, urine	<1%	6,183	$787.26
76870		<1%	411	$786.81
76830	Ultrasound, transvaginal	<1%	317	$779.32
97161		<1%	4,914	$715.70
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,782	$713.33
76801		<1%	389	$706.45
93880		<1%	286	$702.56
84100		<1%	6,001	$700.48
0250		<1%	2,374	$690.17
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	5,543	$671.24
76536		<1%	161	$646.43
87340		<1%	2,160	$646.30
72170		<1%	695	$625.12
97162		<1%	3,628	$588.65
76512		<1%	205	$584.92
86706		<1%	1,478	$582.12
86900		<1%	2,016	$577.40
86901		<1%	2,466	$571.13
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	110,597	$564.89
82274		<1%	10,984	$541.80
70491		<1%	49	$535.90
90677		<1%	2,905	$527.15
86140		<1%	1,934	$524.13
93307		<1%	79	$516.56
97010		<1%	2,472	$510.80
84481		<1%	456	$503.20
83880		<1%	237	$487.65
73090		<1%	750	$484.78
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	2,889	$474.46
86705		<1%	923	$468.86
92550		<1%	638	$468.15
84484		<1%	835	$467.85
82607		<1%	1,196	$454.07
83550		<1%	1,405	$449.17
83540		<1%	1,529	$446.42
75574		<1%	29	$431.02
92567		<1%	1,149	$430.46
72100		<1%	559	$429.90
70498		<1%	79	$429.81
29705		<1%	1,215	$404.67
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,120	$400.38
73552		<1%	305	$389.25
73140		<1%	1,297	$385.03
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	650	$384.30
92551		<1%	1,207	$367.28
J2704	Injection, propofol, 10 mg	<1%	5,255	$367.20
97166		<1%	877	$359.33
80305		<1%	4,386	$358.97
J7030	Infusion, normal saline solution , 1000 cc	<1%	13,108	$355.15
99442		<1%	45,424	$354.45
86160		<1%	298	$348.19
90472	Immunization administration, each additional vaccine (list separately)	<1%	2,163	$341.07
81025		<1%	2,853	$335.00
10060		<1%	12	$318.55
90723		<1%	134	$315.51
85652		<1%	1,956	$311.17
51798		<1%	629	$309.37
88307		<1%	775	$304.96
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,718	$302.56
93308		<1%	956	$297.54
J2270	Injection, morphine sulfate, up to 10 mg	<1%	6,349	$290.71
51702		<1%	428	$290.48
90651		<1%	1,626	$288.34
87186		<1%	2,096	$287.93
29075		<1%	315	$287.43
82746		<1%	360	$285.70
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	1,404	$283.97
92227		<1%	2,269	$271.94
52000		<1%	120	$271.79
76825		<1%	274	$267.77
82378		<1%	246	$261.88
12001		<1%	13	$260.29
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	239	$253.02
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	12,282	$248.92
92228		<1%	425	$238.37
82565		<1%	3,262	$229.50
85007		<1%	2,113	$222.62
90739		<1%	1,062	$220.23
0296T		<1%	207	$218.18
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	492	$215.79
82570		<1%	1,182	$209.78
73620		<1%	306	$202.09
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	5,526	$202.01
90750		<1%	2,784	$200.34
76775		<1%	169	$189.78
99242		<1%	429	$184.91
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	14,851	$180.70
99443		<1%	14,700	$179.67
86592		<1%	1,184	$177.48
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	1,894	$173.69
98960		<1%	2,902	$169.10
90633		<1%	1,368	$163.48
J1170	Injection, hydromorphone, up to 4 mg	<1%	5,251	$162.94
90694		<1%	44	$162.00
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,308	$159.44
87088		<1%	3,202	$159.07
74018		<1%	956	$154.42
99441		<1%	20,333	$151.99
84403		<1%	149	$151.69
81003		<1%	2,567	$149.87
J7120	Ringers lactate infusion, up to 1000 cc	<1%	3,895	$147.96
99201		<1%	1,333	$147.64
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	580	$146.26
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	91	$145.53
77080		<1%	173	$143.22
73060		<1%	255	$142.06
90686		<1%	4,520	$140.60
92083		<1%	655	$139.97
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,065	$136.51
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	30	$135.29
93017		<1%	105	$134.75
90696		<1%	604	$131.78
J8540	Dexamethasone, oral, 0.25 mg	<1%	3,528	$129.94
97165		<1%	650	$129.35
86334		<1%	82	$120.03
92504		<1%	667	$116.57
83690		<1%	223	$105.70
73562		<1%	687	$105.66
88304		<1%	1,319	$103.01
87338		<1%	1,527	$99.49
81000		<1%	2,802	$97.83
86225		<1%	205	$95.66
90648		<1%	685	$92.52
91300		<1%	1,095	$91.00
90653		<1%	415	$90.18
94729		<1%	561	$89.24
96415		<1%	20	$85.54
29405		<1%	12	$84.41
81002		<1%	2,639	$82.16
86360		<1%	267	$79.69
J1644	Injection, heparin sodium, per 1000 units	<1%	7,651	$77.45
59025	Fetal non-stress test	<1%	953	$77.44
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	421	$76.97
94010		<1%	1,131	$74.96
90746		<1%	598	$74.09
J3475	Injection, magnesium sulfate, per 500 mg	<1%	5,246	$72.56
90700		<1%	605	$72.04
99234		<1%	13	$68.20
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	113	$65.66
83615		<1%	57	$65.10
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	5,901	$63.81
J1630	Injection, haloperidol, up to 5 mg	<1%	1,235	$62.36
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,807	$61.83
31575		<1%	1,746	$59.40
88173		<1%	202	$56.87
84550		<1%	289	$53.96
82248		<1%	347	$53.45
82962		<1%	5,300	$51.45
87210		<1%	1,562	$50.70
84155		<1%	243	$50.40
92283		<1%	15	$50.37
97535	Self-care/home management training, each 15 minutes	<1%	108	$50.31
86920		<1%	3,010	$49.72
73120		<1%	190	$48.45
86304		<1%	59	$47.80
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,784	$47.63
97164		<1%	32	$47.32
72110		<1%	13	$47.25
73502		<1%	97	$46.60
95816		<1%	150	$45.10
92555		<1%	197	$43.83
92235		<1%	29	$40.86
70551	Magnetic resonance imaging, brain; without contrast material	<1%	36	$40.00
83026		<1%	6,480	$37.63
72040		<1%	60	$37.27
92579		<1%	50	$36.48
84156		<1%	256	$36.16
99173		<1%	494	$34.61
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	10,294	$34.07
J2060	Injection, lorazepam, 2 mg	<1%	1,792	$33.70
S5551	Insulin, most rapid onset (lispro or aspart); 5 units	<1%	4,474	$31.60
P9011	Blood, split unit	<1%	358	$30.14
84703		<1%	127	$29.65
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	13,768	$29.34
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	7,949	$27.54
J7050	Infusion, normal saline solution, 250 cc	<1%	12,599	$27.54
S0164	Injection, pantoprazole sodium, 40 mg	<1%	1,243	$27.48
97116		<1%	94	$25.75
83883		<1%	16	$24.18
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,365	$23.22
85008		<1%	194	$23.20
87205		<1%	1,764	$19.25
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,004	$18.59
83001		<1%	24	$18.35
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,110	$17.49
70486		<1%	12	$15.66
0300		<1%	6,085	$15.57
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,230	$14.48
98968		<1%	825	$14.46
88108		<1%	664	$14.43
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	2,324	$13.92
82784		<1%	59	$12.98
85044		<1%	109	$12.96
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	1,268	$11.02
83721		<1%	25	$10.40
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	953	$10.19
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	983	$9.92
96127		<1%	16	$9.52
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	3,473	$8.12
87070		<1%	727	$7.51
87015		<1%	15	$6.61
87081		<1%	2,171	$5.62
J1650	Injection, enoxaparin sodium, 10 mg	<1%	8,124	$5.26
87581		<1%	46	$4.95
85018		<1%	33	$4.70
94200		<1%	131	$4.43
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	652	$4.13
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	3,447	$1.43
86708		<1%	45	$0.64
0130		0%	2,838	$0.00
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	0%	2,801	$0.00
S5550	Insulin, rapid onset, 5 units	0%	1,360	$0.00
88300		0%	228	$0.00
99386		0%	710	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	724	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	2,873	$0.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	0%	5,916	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	1,815	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	1,377	$0.00
99243		0%	796	$0.00
J9202	Goserelin acetate implant, per 3.6 mg	0%	637	$0.00
3052F		0%	990	$0.00
3079F		0%	4,744	$0.00
0110		0%	789	$0.00
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	0%	1,017	$0.00
94760		0%	255	$0.00
99385		0%	769	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	1,288	$0.00
83605		0%	305	$0.00
80422		0%	2,220	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	168	$0.00
99241		0%	18	$0.00
87040		0%	164	$0.00
0636		0%	3,484	$0.00
J9045	Injection, carboplatin, 50 mg	0%	213	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	546	$0.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	0%	97	$0.00
A9152	Single vitamin/mineral/trace element, oral, per dose, not otherwise specified	0%	241	$0.00
98967		0%	755	$0.00
T1014	Telehealth transmission, per minute, professional services bill separately	0%	1,723	$0.00
3074F		0%	24,008	$0.00
99024		0%	1,739	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	168	$0.00
90656		0%	2,187	$0.00
96161		0%	1,287	$0.00
0771		0%	6,149	$0.00
31231		0%	193	$0.00
S0020	Injection, bupivicaine hydrochloride, 30 ml	0%	75	$0.00
80047		0%	14	$0.00
99384		0%	55	$0.00
59414		0%	333	$0.00
93930		0%	13	$0.00
99606		0%	115	$0.00
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	0%	56	$0.00
J3490	Unclassified drugs	0%	1,201	$0.00
C1781	Mesh (implantable)	0%	12	$0.00
36410		0%	96	$0.00
99383		0%	135	$0.00
99174		0%	93	$0.00
73503		0%	37	$0.00
19083		0%	120	$0.00
J3430	Injection, phytonadione (vitamin k), per 1 mg	0%	12	$0.00
3075F		0%	6,618	$0.00
93922		0%	64	$0.00
88187		0%	255	$0.00
3080F		0%	1,705	$0.00
81015		0%	636	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	74	$0.00
45380	Colonoscopy, flexible; with biopsy, single or multiple	0%	14	$0.00
86762		0%	25	$0.00
74230		0%	12	$0.00
90674		0%	120	$0.00
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	0%	64	$0.00
3044F		0%	9,205	$0.00
73560		0%	86	$0.00
86593		0%	12	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	37	$0.00
1111F		0%	18,889	$0.00
S5553	Insulin, long acting; 5 units	0%	83	$0.00
76519		0%	16	$0.00
99406		0%	13	$0.00
96910		0%	34	$0.00
J9299	Injection, nivolumab, 1 mg	0%	15	$0.00
84540		0%	14	$0.00
90716		0%	53	$0.00
91307		0%	25	$0.00
99465		0%	13	$0.00
93280		0%	13	$0.00
J0500	Injection, dicyclomine hcl, up to 20 mg	0%	12	$0.00
59410		0%	12	$0.00
90743		0%	33	$0.00
1220F		0%	22	$0.00
J0456	Injection, azithromycin, 500 mg	0%	19	$0.00
93990		0%	13	$0.00
74330		0%	13	$0.00
84300		0%	23	$0.00
85060		0%	384	$0.00
C9257	Injection, bevacizumab, 0.25 mg	0%	917	$0.00
G9920	Screening performed and negative	0%	5,806	$0.00
84145		0%	20	$0.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	7,882	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	279	$0.00
36600		0%	1,394	$0.00
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	0%	245	$0.00
3051F		0%	1,794	$0.00
86922		0%	193	$0.00
96160		0%	973	$0.00
86003		0%	30	$0.00
J0694	Injection, cefoxitin sodium, 1 gm	0%	101	$0.00
94150		0%	26	$0.00
3046F		0%	1,571	$0.00
98966		0%	1,143	$0.00
3077F		0%	6,157	$0.00
77062		0%	101	$0.00
93770		0%	56	$0.00
J9263	Injection, oxaliplatin, 0.5 mg	0%	250	$0.00
97163		0%	114	$0.00
J9271	Injection, pembrolizumab, 1 mg	0%	321	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	139	$0.00
90734		0%	900	$0.00
0120		0%	787	$0.00
G9919	Screening performed and positive and provision of recommendations	0%	208	$0.00
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	0%	1,624	$0.00
J7642	Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram	0%	1,895	$0.00
99245		0%	646	$0.00
90707		0%	30	$0.00
99382		0%	215	$0.00
92611		0%	12	$0.00
0731		0%	62	$0.00
99421		0%	44	$0.00
3078F		0%	27,573	$0.00
S0030	Injection, metronidazole, 500 mg	0%	650	$0.00
90791	Psychiatric diagnostic evaluation	0%	44	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	185	$0.00
J2590	Injection, oxytocin, up to 10 units	0%	183	$0.00
83655		0%	56	$0.00
88302		0%	14	$0.00
97168		0%	80	$0.00
80348		0%	214	$0.00
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	0%	152	$0.00
90661		0%	262	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	107	$0.00
36555		0%	37	$0.00
93970		0%	51	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	79	$0.00
99605		0%	20	$0.00
51741		0%	97	$0.00
94726		0%	63	$0.00
99244	Office or other outpatient consultation, moderate to high complexity	0%	175	$0.00
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	0%	66	$0.00
91312		0%	40	$0.00
93041		0%	943	$0.00
92552		0%	29	$0.00
G0390	Trauma response team associated with hospital critical care service	0%	29	$0.00
93224		0%	15	$0.00
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	0%	64	$0.00
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	0%	23	$0.00
S0028	Injection, famotidine, 20 mg	0%	240	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	47	$0.00
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	0%	87	$0.00
94727		0%	14	$0.00
86765		0%	69	$0.00
Q5116	Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg	0%	95	$0.00
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	0%	31	$0.00
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	0%	24	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	59	$0.00
67028	Intravitreal injection of a pharmacologic agent	0%	15	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	25	$0.00
J1453	Injection, fosaprepitant, 1 mg	0%	50	$0.00
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	0%	74	$0.00
77012		0%	12	$0.00
96900		0%	192	$0.00
J9060	Injection, cisplatin, powder or solution, 10 mg	0%	29	$0.00
J1750	Injection, iron dextran, 50 mg	0%	30	$0.00
90473		0%	24	$0.00
75989		0%	16	$0.00
0124A		0%	45	$0.00
73070		0%	14	$0.00
89050		0%	15	$0.00
J3250	Injection, trimethobenzamide hcl, up to 200 mg	0%	20	$0.00
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	0%	19	$0.00
85014		0%	13	$0.00
86039		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTURNER, ANDREA (CEO)

Same official

Other billing entities under TURNER, ANDREA

Full network →

Provider	Location	Paid
County of Los Angeles	Torrance, CA	$96.48M
County of Los Angeles	Torrance, CA	$71.60M
County of Los Angeles	Torrance, CA	$730K
County of Los Angeles	Torrance, CA	$487K
County of Los Angeles	Harbor City, CA	$13K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.